Changes of antioxidant enzyme activity and heat shock protein content in lymphocytes of children with asthma by Perišić, Tatjana et al.
INTRODUCTION
Asthma is a chronic pulmonary disorder char‑
acterized by airway inflammation. Many experi‑
mental and clinical data suggest that oxidative 
stress is increased in asthmatic children and adults 
(K i r k h a m   and  R a h m a n  , 2006; Va c h i e r   et 
al., 1994; S h a n m u g a s u n d a r a m   et al., 2001; 
L i a o   et al., 2004;  M a k   et al., 2004). Impairment 
of the antioxidant system and/or excessive produc‑
tion of reactive oxygen species by inflammatory 
cells, which overwhelms host antioxidant defenses, 
are well recognized mechanisms of molecular and 
cellular damage and dysfunction in the airways. 
These mechanisms are believed to contribute to the 
pathophysiology of asthma.
To minimize the harmful effects of an oxidative 
burden, cells are endowed with a variety of defense 
mechanisms. Antioxidant enzymes constitute the 
main protection against free radical‑mediated inju‑
ry. The bulk of reactive species detoxification is 
achieved through a two‑step pathway in which the 
superoxide anion (O2˙ˉ) is converted to another 
oxidant [hydrogen peroxide (H2O2)] by superoxide 
dismutase (SOD), and H2O2 is chemically neu‑
tralized by catalase (CAT). There are two intra‑
cellular SOD isoforms in mammals: cytoplasmic 
copper/zinc SOD (CuZnSOD) and mitochondrial 
manganese SOD (MnSOD). In regard to asthma, 
these enzymes are believed to play a significant role 
against oxidative stress in lung (K i n n u l a   and 
C a r p o , 2003; C o m h a i r   et al., 2005; S m i t h 
et al., 1997; G n o s h   et al., 2006) and blood 
(S h a n m u g a s u n d a r a m   et al., 2001; M a k   et 
al., 2004; P e n n i n g s   et al., 1999) cells, but also 
in plasma or serum (L i a o   et al., 2004), which are 
predominantly investigated in pediatric patients.
As the most studied and best understood effec‑
tors of the cellular stress response, heat shock 
proteins (HSPs) are also recognized as major com‑
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ponents of the cytoprotective system. Among many 
members of this large protein family, Hsp70 and 
Hsp90 are designated as key molecular chaperones 
participating in folding and maturation of multiple 
components of signal transduction pathways. Protein 
folding and denaturation are particularly enhanced 
during various stressful conditions, including oxi‑
dative stress. The findings that Hsp70 and Hsp90 
are modulated by oxidizing conditions (P o l l a   et 
al., 1996; M é n o r e t   et al., 2002;  N a r d a i   et al., 
2000) and by antioxidant supplements (P e n g   et 
al.,  2000) support the regulatory role of oxidant/
antioxidant balance in heat shock protein expres‑
sion (C a l a b r e s e   et al., 2006). HSPs generally 
perform a protective function, but can also amplify 
an inflammatory response. These proteins, particu‑
larly Hsp70, have a capacity to stimulate expression 
of proinflammatory cytokines and induce anti‑
gen‑specific immunity (P o c k l e y   et al., 2003). A 
recent study has shown that Hsp70 overexpression 
is correlated with upregulation of HLA‑DR surface 
molecules in bronchoalveolar lavage (BAL) cells and 
bronchial biopsies of asthmatics, giving rise to the 
hypothesis that Hsp70 has a potential role in antigen 
processing and/or presentation (B e r t o r e l l i   et 
al., 1998). Despite their still unresolved (protective, 
amplificatory, or dual) role in inflammation and 
asthma (P o l l a   et al., 1998), the elevated expres‑
sion of HSPs is considered to be indicative of an 
enhanced cellular stress response. Moreover, the 
data on their potential impact on childhood asthma 
are scarce.
In light of the importance of antioxidative 
defense mechanisms and the heat shock response 
for cellular defense against oxidative stress, and 
hence, for the pathogenesis of asthma, the purpose 
of this study was to compare the activities of key 
antioxidant enzymes (CAT, SODs) and levels of 
HSPs (Hsp70, Hsp90) in asthmatic and healthy chil‑
dren. Being performed on subjects suffering from 
mild and moderate asthma, the study is designed to 
provide new information on possible association of 
the studied enzyme activities and expression of the 
HSPs with asthma severity. To conduct this study, 
circulating blood mononuclear cells were used since 
they play a prominent role in the inflammatory pro‑
cess and have been shown to contribute to elevated 
oxidative stress in asthma. 
MATeRIALS AND MeTHODS
Patients
A total of 40 children were enrolled in the study. 
They were recruited from the outpatient clinic of the 
Children’s Hospital for Tuberculosis and Pulmonary 
Diseases. The population consisted of 28 children 
with two different degrees of asthma severity (11 
with mild persistent asthma and 17 with moder‑
ate persistent asthma) and 12 age‑matched healthy 
controls attending the clinic for unrelated condi‑
tions. All patients with asthma were diagnosed by 
well‑known criteria, that is, clinical symptoms and 
lung function measurements according to Global 
Strategy for Asthma Management (NIH publication 
no. 02‑3659, Bethesda, 2002). Based on a history of 
physician‑diagnosed asthma and medication used, 
patients with FeV1 of ≥ 80% of predicted variability 
or peak expiratory flow (PeF) variability between 
20 and 30% combined with occasional symptoms 
were classified as mild persistent asthmatics, while 
patients with FeV1 of 60 to 80% of predicted vari‑
ability or PeF variability of 30% with daily symp‑
toms were classified as moderate persistent asth‑
matics. eligibility criteria included a documented 
asthma diagnosis during the last 12 months or 
longer, and age between 8 and 18 years. exclusion 
criteria included: (1) other chronic lung disease, 
(2) treatment with oral or inhaled corticosteroids 
during the last four weeks, (3) treatment with anti‑
histamines and theophylline during the last two 
weeks, (4) treatment with β2‑agonists during the 
last 48 hours and (5) asthma exacerbations during 
the last 8 weeks. For control patients, the eligibility 
criteria included normal lung function, good health, 
and age between 8 and 18 years, while the exclusion 
criteria were diagnosis of asthma and upper or lower 
respiratory tract infection during the last 4 weeks. 
Blood drawing appointments were set if and when 
the patient fulfilled the inclusion criteria and none 
of the exclusion ones.
Atopic status was assessed by the skin‑prick 
test for common allergens (feathers, home dust, 
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mould, dust mites, cockroaches, tobacco, animal 
hair, Dermatophagoides pteronyssinus, bacteria, tree 
pollen, grass pollen, weed pollen, Ambrosia artemi-
siifolia). Physiological solution and histamine served 
as controls. 
The children and their parents were informed 
of the purpose of the study and gave their consent. 
The ethics Committee of the Dr. Dragiša Mišović 
Clinical Center approved the study protocol. 
Blood sampling and cell isolation
After the patient was made comfortable, blood 
was obtained by venipuncture in heparinized tubes 
(25 U/ml) between 8:30 and 9:30 a.m. The samples 
were immediately taken to the laboratory and cells 
were isolated within one hour from blood drawing.
To isolate peripheral blood mononuclear cells 
(PBMCs), blood was diluted with an equal volume 
of phosphate buffer saline (PBS) (0.14 mmol/l NaCl, 
2.7 mmol/l KCl, 1.5 mmol/l KH2PO4, 6.5 mmol/l 
Na2HPO4; pH 7.2) and subjected to density gradient 
centrifugation over Ficoll‑Hypaque Plus (Amersham 
Biosciences) at 380xg for 30 min at 23 ºC. The cells 
were collected, washed two times with PBS and the 
pellet was stored in liquid nitrogen until analysis. 
Cellular protein extraction
For protein extraction, cellular pellets were 
resuspended in ice‑cold hypotonic lysis buffer (50 
mmol/l NaCl, 5% glycerol, 0.5% Triton X‑100, 
2 mmol/l ethylenediaminetetraacetic acid and 50 
mmol/l Tris; pH 7.5) supplemented with a com‑
plete protease inhibitor cocktail (Roche Diagnostics 
GmbH) using 15 μl of extraction buffer per 1×106 
cells. Following incubation on ice for 15 min and 
two freeze/thaw cycles, the lysate was centrifuged 
at 13,000xg for 15 min at 4 ºC. The supernatants, 
referred to as cell extracts, were stored in small 
portions at ‑75ºC. Protein concentration, estimated 
using bovine serum albumin as standard, ranged 
from 3 to 6 μg/μl.
Measurement of SOD and CAT enzyme activities
Cell extracts were diluted 1:1 with native sample 
buffer (10% glycerol, 0.0075% bromphenol blue 
and 62.5 μmol/l Tris; pH 6.8) and non‑denaturing 
polyacrylamide gel electrophoresis (PAGe) was per‑
formed using a Mini‑Protean II electrophoresis Cell 
(Bio‑Rad Laboratories, Hercules, CA). Lanes were 
loaded with 100 μg of protein and electrophoresis 
was run at a constant voltage of 120 V through 1 
mm‑thick 11% polyacrylamide (PA) gel (30% T, 
2.7% Cbis) in Tris‑glycine running buffer (pH 8.3). 
SOD activity was detected in the gel by the modi‑
fied method of B e a u c h a m p   and  F r i d o v i c h 
(1971). The gel was incubated in the dark in a solu‑
tion containing 0.5 mmol/l nitroblue tetrazolium 
(NBT; Sigma Chemical Co., USA) and 50 mmol/l 
potassium phosphate (pH 7.8) for 15 min, fol‑
lowed by a 15 min soak in 28 μmol/l riboflavin and 
28 mmol/l tetramethylethylenediamine (TeMeD; 
Sigma Chemical Co., USA) solution. Subsequently, 
the gel was illuminated on a light box for 25 min 
until clear SOD bands appeared on a dark purple 
background. The isoforms were identified by add‑
ing 5 mM H2O2 and 5 mM KCN to buffered NBT 
solutions, CuZnSOD being sensitive and MnSOD 
unaffected by the treatment (data not shown).
For analysis of CAT activity, 1 mm‑thick 6% 
PA gel was loaded with 100 μg of total protein and 
native PAGe was performed under the conditions 
as described above. The gel was thoroughly washed 
with dH2O and after 10 min of incubation in 0.007% 
H202 was quickly rinsed with dH2O. A freshly pre‑
pared mixture of 2% ferric chloride and 2% potas‑
sium ferricyanide was poured over the gel. When 
clear bands of CAT activity appeared on a green 
background, the reaction was stopped by replacing 
the staining mixture with 7% acetic acid and a 5% 
methanol solution. Stained gels were scanned with 
an Ultra‑Lum GeL eXPLOReR Imaging System 
(Claremont, CA).
Western blot analysis of heat shock proteins
Cell extracts were reduced and denatured by 
5‑min treatment at 95 ºC with buffer containing 
62.5 μmol/l Tris (pH 6.8), 2% SDS, 10% glycerol, 5% 
β‑mercaptoethanol, and 0.0075% bromphenol blue. 
Proteins (70 μg per lane) were resolved on 7.5% 
SDS‑PA gel, together with protein molecular mass 
standards (29‑205 kDa; Sigma Chemical Co., USA). 
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After overnight immunoblotting, PVDF membranes 
(Hybond‑P, Amersham Biosciences) were incubated 
in blocking buffer containing 2.5% nonfat dry milk 
in PBS (pH 7.2) for 1.5 h at room temperature and 
then probed with an appropriate primary anti‑
body. The primary antibodies used were: SPA‑830, 
raised against mouse Hsp90 (Stressgen Bioreagents, 
Victoria, BC, Canada; working dilution of 1:2,000); 
SPA‑820 (Stressgen Bioreagents; 1:2,000) which rec‑
ognizes both constitutive (Hsc70) and inducible 
(Hsp72) isoforms of Hsp70; SPA‑810, which is spe‑
cific for Hsp72 (Stressgen Bioreagents; 1:500); and 
anti‑β‑actin (Sigma Chemical Co., USA; 1:8,000). 
After incubation with primary antibodies and three 
cycles of washing with PBS containing 0.1% Tween 
20, the membranes were incubated with alkaline 
phosphatase‑conjugated secondary antibody for 1 
h. The immunoreactive proteins were visualized 
on STORM (Amersham Pharmacia Biotech UK 
Limited, england) by the enhanced chemifluores‑
cent method.
Quantitative analysis of Western blots and gels
each lane was loaded with an equal amount of 
protein, the β‑actin bands serving as the equal load 
control for Western blot analysis. To make quantita‑
tive comparisons between multiple immunoblots 
or enzyme assays reliable, i.e., to counterbalance 
inter‑gel variations, an internal reference sample 
(cellular extract from PBMCs donated by a healthy 
adult female volunteer) was run on each gel. Prior 
to any comparison, the intensity of each analyzed 
band was normalized to the intensity of the respec‑
tive internal reference band on the same blot or gel. 
Relative integrated optical density of immunoreac‑
tive bands was measured using Image Quant soft‑
ware (Amersham Biosciences Limited, UK) and the 
results are expressed in arbitrary units (AU).
Statistical analysis
Nonparametric tests were used to analyze the 
data. Differences between groups are presented as 
mean differences with a 95% confidence interval. 
The Kruskal‑Wallis test, with a subsequent post hoc 
test, was performed for comparison of the three 
groups of patients. Between‑group comparisons 
were assessed by the Mann‑Whitney U‑test. A 
two‑tailed p value of less than 0.05 was considered 
significant. Statistical comparisons were carried out 
using the GraphPad Prism v4.0 software (GraphPad 
Prism Software Inc., San Diego, CA).
ReSULTS
Healthy children and children with mild asthma 
were similar (p=0.3) in terms of age, 16.1 ± 0.5 years 
(mean ± Se, n=12, range 13‑18) and 14.6 ± 0.9 years 
(mean ± Se, n=11, range 9‑18), respectively. The 
average age of children with moderate asthma was 
13.7 ± 0.6 years (mean ± Se, n=17, range 8‑17), and 
they were significantly younger (p=0.01) than the 
healthy subjects. The male to female ratio was six 
to six in the healthy group of children, six to five 
in the group of mild asthmatics, and 14 to three in 
the group of moderate asthmatic children. Duration 
of the disease was similar (p=0.1) in both groups 
of asthmatic children: 7.8 ± 1.4 years (mean ± Se, 
range 1‑13.5) in mild and 10.8 ± 0.8 years (mean 
± Se, range 5‑16) in moderate asthmatics. Atopy 
was detected in one healthy patient, as well as in 
nine mild and 15 moderate asthmatics. The num‑
ber of subjects tested by different methods varied 
throughout the study, reductions in size of a sample 
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Fig. 1. MnSOD and CuZnSOD activity in PBMCs of healthy 
children and children with mild and moderate asthma. (A) A 
representative gel depicting SOD activities in PBMCs of two 
healthy children (lanes 1 and 2), two mild asthmatics (lanes 3 
and 4), and three moderate asthmatics (lanes 5, 6, and 7). (B) 
Graphical presentation of individual data for CuZnSOD (left 
panel) and MnSOD (right panel) activities. Horizontal bars 
represent the mean values.*: p<0.05
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being due to limited amounts of blood available and 
PBMC yields from certain patients.
To measure activity of the antioxidant enzymes 
SOD and CAT, enzymatic gel assays were performed. 
Activities of both CuZnSOD and MnSOD were 
detected in PBMCs of all examined subjects (n=36). 
Quantitative analysis of SOD bands showed that 
CuZnSOD activity in PBMCs of children with mod‑
erate asthma was significantly higher (p=0.01) than 
in healthy children. The relative level of CuZnSOD 
activity found in children with mild asthma was 
lower compared to that in the group of moderate 
asthmatics, but the difference was not statistically 
significant. Similarly, there were no statistically sig‑
nificant differences of MnSOD activity between the 
three groups of patients (Fig. 1). 
The results of CAT activity measurements in 
PBMCs of 20 asthmatic and eight healthy children 
are shown in Fig. 2. The level of CAT activity was 
found to be unaltered (p=0.2) in both groups of 
asthmatic patients in comparison to healthy chil‑
dren. The ratio of CuZnSOD to CAT activity, as an 
indicator of antioxidative enzyme (dis)balance, was 
significantly higher (p=0.04) in PBMCs of moder‑
ate asthmatic patients compared to healthy chil‑
dren, while differences between mild asthmatic and 
Fig. 2. CAT activity in PBMCs of healthy children and chil-
dren with mild and moderate asthma. (A) A representative gel 
shows results obtained for two healthy children (lanes 1 and 2), 
two children with mild (lanes 3 and 4), and three with moder-
ate asthma (lanes 5, 6, and 7). (B) Graphical presentation of the 
individual data. Horizontal bars represent the mean values.
Fig. 3. Western blot analysis of Hsp70 expression in PBMCs of healthy children and children with mild and moderate asthma. (A) 
Western blot showing immunoreactive bands corresponding to both Hsp70 isoforms. (B) Individual data on expression of Hsp70. 
The representative bands are shown above the appropriate scattergrams. Horizontal bars represent the means. (C) Western blots 
showing Hsp72 expression in PBMCs isolated from four healthy children (lane 1), four mild asthmatics (lane 2), and four moderate 
asthmatics (lane 3). (D) Relative integrated optical density of Hsp72 bands.
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healthy children were not observed.
In order to examine the level of Hsp70 expres‑
sion by Western blot analysis, two different mono‑
clonal antibodies were applied: one recognizing 
both the constitutive (Hsc70) and the inducible 
(Hsp72) form of the protein, the other recogniz‑
ing only Hsp72. Intensities of the immunoreactive 
bands corresponding to total Hsp70 (Hsc70+Hsp72) 
were similar (p=0.5) in all studied groups of patients 
(Fig. 3A and B). However, the relative amount of 
the Hsp72 isoform was higher in moderate asth‑
matic patients than in mild asthmatics and healthy 
controls. Since the sample size for this analysis was 
rather small, with a total of four subjects per group, 
the results obtained for each individual patient are 
presented (Fig. 4C and D) and statistical analysis 
was not performed.
Western blot analysis revealed significant 
increase of Hsp90 expression in PBMCs of moder‑
ate asthmatics when compared to mild asthmatics 
(p=0.01) and healthy children (p=0.01) (Fig. 4).
DISCUSSION
The present study provides evidence indicat‑
ing a disequilibrium in the activity of antioxidant 
enzymes in PBMCs of children with moderate 
asthma. This disequilibrium is manifested as an 
increase in the ratio of CuZnSOD to CAT activ‑
ity in moderate asthmatics as compared to healthy 
children. To our knowledge, this is the first study 
examining relative activity of both intracellular SOD 
isoforms in childhood asthma. In PBMCs of mod‑
erate asthmatic patients, the activity of CuZnSOD 
was higher in comparison to healthy children, while 
that of MnSOD was similar in all three groups of 
subjects. The observed changes in antioxidant sta‑
tus are accompanied by elevated Hsp90 and Hsp72 
expression. 
The increase of SOD activity in moderate asth‑
matics, which can be ascribed solely to the cytoplas‑
mic CuZnSOD isoform, is likely to reflect compart‑
mentalized activity of the cell’s antioxidant system. 
In keeping with the concept of “microdomain‑spe‑
cific signaling”, which is based on spatial organiza‑
tion of oxidant production and antioxidant activity 
in the cell  (Te r a d a , 2006), increased activity of the 
CuZnSOD isoform parallel with unaltered MnSOD 
activity could indicate that the predominant source 
of superoxide anions in PBMCs of moderate asth‑
matic children resides in the cytoplasm rather than 
in mitochondria. Our results are in agreement with 
studies that showed increased superoxide produc‑
tion in asthmatic patients without addressing the 
source of the radical. For example, an increase 
in O2˙ˉ production from peripheral blood cells 
was registered in stable adult asthmatic patients 
(Va c h i e r   et al., 1994) and concentration of the 
superoxide anion was found to be elevated in the 
erythrocytes of symptom‑free children with asthma 
(S h a n m u g a s u n d a r a m   et al., 2001).
Although evaluation of the serum antioxidant 
capacity in asthmatic children (L i a o   et al., 2004) 
and antioxidant status in red blood cells of asthmatic 
adults (M a k   et al., 2004) showed an increase in 
SOD activity, recent findings suggest that SOD could 
be modulated by oxidative and nitrative reactive spe‑
cies and thus susceptible to inactivation, especially 
Fig. 4. Western blot analysis of Hsp90 in PBMCs of healthy 
children and children with mild and moderate asthma. (A) A 
representative Western blot showing Hsp90 expression. The 
representative bands are shown above the appropriate scat-
tergrams. (B) Graphical presentation of the individual data. 
Horizontal bars represent the mean values. *; p<0.05.
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by the powerful oxidant peroxinitrite (Q u i n t   et 
al., 2006; A l v a r e z   et al., 2004). These mechanistic 
studies were extended by research on the molecu‑
lar basis of asthma pathophysiology conducted by 
C o m h a i r   et al. (2005), who presented evidence 
for MnSOD inactivation in bronchial cells of asth‑
matic patients. The loss of MnSOD activity was 
correlated with physiological parameters of asthma 
in vivo and with apoptosis in airway epithelial cells. 
A direct correlation was also demonstrated between 
bronchial hyperreactivity in asthmatic patients and 
total SOD inactivation in BAL cells and bronchial 
brushing (S m i t h   et al., 1997). On the contrary, we 
found increased activity of CuZnSOD in the group 
of children with more severe asthma, while the level 
of this enzyme’s activity in PBMCs of mild asthmatic 
and healthy children was comparable. These dis‑
crepancies could be explained in several ways.
First of all, as opposed to the mentioned studies, 
the recruited asthmatic patients were classified into 
two homogeneous groups based on asthma sever‑
ity, which enabled us to detect subtle differences of 
enzyme activity between different degrees of asthma 
severity. In the second place, the patients selected 
for our study were not treated with corticosteroids. 
Glucocorticoids are known to suppress the inflam‑
matory response and have been shown to influence 
superoxide anion production. Superoxide release 
by mouse peritoneal macrophages in vitro was 
shown to be rapidly inhibited after glucocorticoid 
treatment (L o n g   et al., 2005), as is the release by 
monocytes in treated asthmatic patients (M a j o r i 
et al., 1998). We reasoned that enrolling stable and 
untreated patients would exclude the antioxidant 
and anti‑inflammatory effects of this treatment on 
target molecules. Thus, the discrepancies might be 
attributable to differences of study design. Thirdly, 
there are no studies on the difference of SOD activ‑
ity between asthmatic adults and children, but there 
may well be differences between childhood and 
adult asthma (B r o w n   et al., 2005). Numerous 
studies have established the role of cytokine‑medi‑
ated inflammation in the chronicity of asthma, and 
there is considerable evidence indicating that age 
is among the most important variables in cytokine 
expression (K r u g   et al., 1998). In addition, SODs 
are induced and regulated by inflammatory cyto‑
kines (M a r k l u n d , 1992). Thus, the age of subjects 
enrolled in this study could be a confounding factor. 
Finally, based on the data available, the possibility of 
cell‑specific differences in CuZnSOD and MnSOD 
activities cannot be excluded. Studies along these 
lines performed on pediatric subjects are scarce, 
being particularly limited by ethical and practi‑
cal problems of performing invasive procedures of 
sample collection for research purposes only.
CAT activity is herein reported to be unaltered in 
asthmatic as compared to healthy children. Similarly, 
the activity of this enzyme did not differ in lungs 
(S m i t h   et al., 1997) and erythrocytes (P e n n i n g s 
et al., 1999) of adult asthmatics as compared to the 
levels in healthy subjects. On the other hand, there 
are studies that reported a decrease of CAT activ‑
ity in patients suffering from asthma. For example, 
a recent proteome survey identified an oxidative 
mechanism of CAT inactivation in asthmatic lungs 
(G n o s h   et al., 2006). N o v á k   et al. (1991) showed 
that blood catalase activity was decreased in stable 
asthmatic children. However, our finding should 
be considered in light of the previously discussed 
increase of CuZnSOD activity. Taken together, our 
results suggest that an increase of CuZnSOD activ‑
ity that is not accompanied by concomitant increase 
of CAT activity could lead to an imbalance between 
H2O2 production and removal. As a consequence of 
the increased ratio of CuZnSOD to CAT activity in 
PBMCs of moderate asthmatics, elevated produc‑
tion of H2O2 could, hypothetically, be expected. A 
similar mechanism of H2O2 accumulation has been 
proposed to support the oxidative stress hypoth‑
esis of Alzheimer disease pathology (G s e l l   et al., 
1995) and has been shown to contribute to cellular 
senescence in the aging process (d e  H a a n   et al., 
1996). Most importantly, an increased H2O2 level 
has been measured in exhaled breath condensate 
of stable asthmatic children, particularly those not 
treated with glucocorticoids (j o b s i s   et al., 1997). 
Data indicating an imbalance in the functional com‑
plex of enzymes that are a potential source of H2O2 
also raise a question as to the well‑known ability 
of this oxidant to inhibit SOD activity. Taking into 
account that the patients included in this study were 
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asymptomatic, we assume that in the period prior 
to and during an acute asthma attack, the elevation 
of inflammatory mediators would cause additional 
increase of CuZnSOD activity and a consequent rise 
in the concentration of H2O2, consecutively lead‑
ing to a subsequent loss of enzyme activity. Such an 
assumption is supported by the study of C o m h a i r 
et al. (2005), who reported rapid loss of SOD activity 
during an asthma attack experimentally induced in 
asthmatic patients.
It has been proposed that HSPs could also play 
a role in asthma. In line with this proposal, the 
expression of Hsp70 in airway cells of asthmatics 
was found to be elevated and correlated with dis‑
ease severity (V i g n o l a   et al., 1995). In our study, 
when the expression of Hsp70 was followed using an 
antibody that recognizes both the inducible (Hsp72) 
and the constitutive (Hsc70) isoform of the protein, 
differences between healthy and asthmatic children 
were not observed. However, although performed 
on a small number of subjects, examination of the 
level of the Hsp72 isoform provided evidence for 
higher abundance of this isoform in PBMCs from 
children suffering from a more severe form of the 
disease in comparison to healthy children and mild 
asthmatics. It is logical to assume that the level of the 
constitutive Hsc70 in PBMCs was high enough to 
mask changes in the level of the inducible member of 
the Hsp70 family. Importantly, P o l l a   et al. (1996) 
demonstrated that Hsp70 prevented H2O2‑induced 
oxidative damage in mitochondria. Higher expres‑
sion of Hsp72 in PBMCs may additionally support 
the hypothesis of M é n o r e t   et al. (2002) that over‑
expression of this protein, under oxidative stress, 
can efficiently stimulate an immune response.
elevated Hsp90 expression in moderately asth‑
matic children has also been observed. There are 
few data on the role and level of Hsp90 expression 
in asthma. Generally, heat shock protein expres‑
sion is stimulated by increased concentrations of 
misfolded proteins, but their role in transmission 
of redox changes in the cell is currently a topic of 
active investigation. Several chaperones (such as 
prokaryotic Hsp33), having highly reactive cysteins, 
are subject to redox control and are readily activated 
in response to an oxidizing insult (such as H2O2 
exposure), thereby protecting cells from oxidative 
damage (j a c o b  et al., 1999). Likewise, specific 
redox‑regulated interactions of Hsp90’s reactive 
cystein residues with cytochrome c suggest a role 
of this chaperone in the regulation of cellular func‑
tions under oxidative stress (N a r d a i  et al., 2000). 
Further studies along these lines are necessary in 
order to elucidate the possible role of Hsp90 overex‑
pression in asthma. 
Results of the present study add to the growing 
body of evidence demonstrating that the pathophys‑
iology of asthma is associated with alterations in the 
level of antioxidants and oxidants. In our study, an 
imbalance in the activities of primary antioxidant 
enzymes was observed in PBMCs of children with 
moderate asthma. However, it is not possible to link 
this imbalance with severity of the disease, since no 
significant differences of antioxidant enzyme activi‑
ties were found between moderate and mild asth‑
matics. On the contrary, the increase in the content 
of Hsp90 and possibly Hsp72 observed in moderate 
vs. mild asthmatics and healthy children suggests 
that alterations in the cellular stress response system 
might be related to severity of the disease. An obvi‑
ous need exists for larger‑scale studies on an even 
wider range of asthma severity in order to establish 
reliable association between antioxidant enzyme 
activities and HSP expression on the one hand, and 
lung function parameters and severity of asthma on 
the other. Such an association might eventually prove 
to be a valid criterion on which to base treatment 
modulation. Recent investigations have reported 
the beneficial effects of new classes of antioxidants 
in reducing the oxidative burden in chronic airway 
diseases (K i r k h a m  and R a h m a n , 2006). They 
could be of particular relevance to pediatric patients, 
considering the adverse effects of long‑term use of 
corticosteroids on growth, skeletal changes, and the 
endocrine system.
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Промене активности антиоксидативних ензима и концентрације 
Протеина тоПлотног стреса у лимфоцитима деце oболeле од астме 
ТаТјана Перишић1, М. Срећковић2 и Гордана МаТић1
1Одељење за биохемију, Институт за биолошка истраживања „Синиша Станковић“, 11000 Београд, Србија
2Дечја болница за плућне болести и туберкулозу, Клиничко-болнички центар „Др Драгиша Мишовић“
11000 Београд, Србија
Циљ ове сту­дије био је да се испита да ли су­ 
промене антиок­сидативног стату­са и ек­спресије 
главних у­ну­тарћелијск­их стрес протеина повеза‑
не са патогенезом астме и тежином овог обоље‑
ња к­од деце. Ак­тивност бак­ар/цинк­ (CuZn)‑ и 
манган (Mn)‑су­перок­сид дисму­тазе (SOD), и 
к­аталазе (CAT) у­ монону­к­леарним ћелијама из 
периферне к­рви 28 деце са стабилном астмом 
(11 са благим и 17 са средње тешк­им облик­ом 
болести) и 12 здраве деце испитана је ензим‑
ск­им тестом у­ нативном гелу­. Концентрације два 
испитивана протеина топлотног стреса, Hsp70 
и Hsp90, одређене су­ техник­ом к­вантитативног 
иму­ноблота. Пацијенти са средње тешк­ом аст‑
мом пок­азали су­ повећану­ ак­тивност CuZn‑SOD 
у­ поређењу­ са здравом децом, док­ разлик­е у­ 
ак­тивности Mn‑SOD и CAT између­ испитиваних 
гру­па пацијената нису­ запажене. Ниво Hsp90 и 
инду­цибилне изоформе Hsp70 био је повећан 
к­од средње тешк­их астматичара у­ поређењу­ са 
благим астматичарима и здравом децом. Резу­л‑
тати у­к­азу­ју­ да дисбаланс у­ ћелијск­ом антиок­си‑
дативном и анти‑стрес систему­ може допринети 
патофизиологији дечје астме, али не мора бити 
повезан са тежином обољења.
